Can an early MS drug dose kickstart nerve repair?
NCT ID NCT05418010
First seen Jan 11, 2026 · Last updated May 13, 2026 · Updated 22 times
Summary
This study tests whether starting the MS drug natalizumab within 14 days of first symptoms can help repair nerve damage in the brain. About 40 adults with early signs of multiple sclerosis will receive either the drug or a placebo for 12 weeks. The goal is to see if quick, strong treatment leads to better long-term outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Royal London Hospital
NOT_YET_RECRUITINGLondon, E1 1FR, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
St George's Hospital
RECRUITINGLondon, SW17 0QT, United Kingdom
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.